Dr. Abbey First in the World to Administer Novel Trispecific Fusion Antibody EB-105 for Diabetic Macular Edema as Part of Phase Ib LOTUS Clinical Trial
On July 9, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase Ib LOTUS trial of EB-105, the world’s first pentavalent trispecific
read moreOur Offices Will Close for Memorial Day
All Texas Retina Associates offices will be closed on Monday, May 27, in observance of Memorial Day. We remember and honor all who gave their lives in service to our country.
read moreWe Love Our Patients!
At Texas Retina, our patients are at the HEART of everything we do. Thank you for placing your trust in us. Happy Valentine’s Day!
read moreHappy New Year!
Happy New Year! Our offices will be closed on Monday, January 1, 2024. As another year comes to a close, we want to thank all of our patients, referring physicians, neighbors and
read moreHappy Veterans Day!
On behalf of everyone at Texas Retina Associates, we would like to extend our deepest gratitude for the sacrifices that our service members, both past and present, have made for our
read moreNew Patient Portal System
Texas Retina Associates is in the process of transitioning to a new and improved patient portal system that will go live on Wednesday, August 9, 2023. This secure portal will provide you
read more